ARMISTICE CAPITAL, LLC has filed 5 insider transactions across 1 company since February 2023.
Most recent transaction: a sale of 2746138 shares of Avalo Therapeutics, Inc. ($AVTX) on June 26, 2023.
Activity breakdown: 2 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 26, 2023 | Avalo Therapeutics, Inc. | $AVTX | ARMISTICE CAPITAL, LLC | TenPercentOwner | S | Common Stock | 2746138 | $0.61 | 1,703,232.0000 | 0 | 61.72% | 0.00% |
| June 27, 2023 | Avalo Therapeutics, Inc. | $AVTX | ARMISTICE CAPITAL, LLC | TenPercentOwner | S | Common Stock | 937404 | $0.52 | 765,828.0000 | 0 | 55.04% | 0.00% |
| Feb. 3, 2023 | Avalo Therapeutics, Inc. | $AVTX | ARMISTICE CAPITAL, LLC | TenPercentOwner | L | Common Stock | 334 | $3.95 | 3,999,370.0000 | 0 | 0.01% | 0.00% |
| Feb. 7, 2023 | Avalo Therapeutics, Inc. | $AVTX | ARMISTICE CAPITAL, LLC | TenPercentOwner | P | Common Stock | 450000 | $0.00 | 4,449,370.0000 | 0 | 11.25% | 0.00% |
| Feb. 7, 2023 | Avalo Therapeutics, Inc. | $AVTX | ARMISTICE CAPITAL, LLC | TenPercentOwner | P | Warrant | 450000 | $0.00 | 450,000.0000 | 0 | 9999.99% | 0.00% |